Member Info for lordloadsoflolly

Hope so, but that'll depend entirely on what the update says.

mol - the reasons might be unclear for OPTI & PBX (possibly just lack ofmanpower?), but Companies House still seems to be waving these extensions through routinely. But that’s likely to change next FY.

Forgive me if I'm behind the curve on this, but Is Harrison Gross related to Clifford? Or are their identical surnames just a coincidence?

BILLBURSIO - fair enough. We all want different things from our investments and will have a different take on them accordingly. I agree P/Es can be a useful guide. But they're largely backward-looking, as any forward P/Es are based on future profit estimates. Whilst I fully expect HAT's P/E to drop significantly over the next 12 months, you perhaps do not. 2020 was really BEFORE HAT started showing its full potential in a slowing economy. So of course the metrics looked better then, as many investors either hadn't spotted where it was heading or didn't believe it would get there. Plus we were in lockdowns for a chunk of that time, when all bets were off. I was lucky enough to anticipate correctly with this share (it doesn't happen often!), buying throughout the FCA investigation period at around £3, again at £2.50 & again just below £2. HAT's been paying me a decent yield ever since, as well as generating a strong capital return to date (though this can really only be judged when I come to sell). Personally, I think this share's got another year or so's growth in it and will temporarily re-rate above £5 at some point during that time. But that's just my hunch and I could well be wrong. As your 2020/22 buy/sale demonstrates, timing is everything with HAT. This is not a share to tuck away & forget. The difference between making 20%-30% and >100% is vast in anyone's language. DA_MATSER - Yes the dilution will have a dividend impact. But that potentially ignores what HAT does with the extra money raised. If it increases its pledge book & store estate prudently using the proceeds, this should lead to higher sales & profits. Which in turn should a) boost the share price and b) allow it to increase dividends further. The spread on this share can be wide, but it also fluctuates. So again, timing can make a significant difference. And as the 3 year figures on the chart link below show, by buying in Oct 20 and selling mid-Sept 22, you’d have made around 114% excluding dividends. Even with a 3% spread, that's a great return! hTTps://www.hl.co.uk/shares/shares-search-results/h/h-and-t-group-ord-gbp0.05

BillBursio - a rising share price doesn’t “devour divvies”, it simply reduces the yield for new buyers. What’s more, HAT has already increased its dividend in line with higher sales & profits and has implied this will continue assuming it continues to grow. So all a bit of a red herring. You were unlucky not to make a lot more than 20% buying in 2020 and selling in 2022. Had you bought in Oct 20 and sold mid-Sept 22, you’d have made 114% excluding dividends.

He’s probably still sleeping off the hangover from his weekend share shindig.

Brighty1 - trust me, it ain’t gonna happen.

Suspect you'll be OK, providing you've a 5 year+ time horizon. But let's face it, nobody knows for sure.

DorsetLSE - I'd second that. But I do also think markets haven't fully factored in the USD/GBP effect yet. After all, if SMT sold all its US holdings today (where it's heavily concentrated) and converted these USD back to GBP, it would make significantly more money now than a week ago. And a hell of a lot more than at the start of this year. At the moment, this had just led to a far greater discount to NAV, but that can change. And it often moves quite rapidly.

It's really only priced to go bust when it's 0p!

zebbo & shandypants - recent revenues were certainly dire. No getting away from that. But I still think geographical spread is a major positive, especially if revenues improve, which looks likely (they could hardly move significantly the other way!). And no zebbo, we're NOT heading to zero. That's just emotive nonsense I'm afraid.

bamb - let's for the moment take it at face value that you emailed the company & got a reply. Since they're prohibited by law from saying anything market-sensitive, it would really all be down to your personal interpretation anyway. I do hope any reply you received wasn't from Tim McDim. You know, the chap who assured everyone just before the FDA's announcement that Phase 3 approval was a given. Until it wasn't.

For me, there are two positives in today's RNS: 1) Cash balance has increased significantly, making further dilution of stakes in SKIN & PBX less likely short term at least. 2) Over half Opti's sales are overseas. So sterling weakness should give a currency headwind to sales & profits going forward (particularly the way Truss-Me-I'm-An-Idiot and Kwasi-I'm-Quite-Kwackers are behaving at the moment).

hardboy - I didn't arrive at 320p! It was BillBursio who threw this random figure out there last Friday. I simply tried to offer valid reasons to discredit it.

fishysaurus - if I had £1 every time someone suggested IQE was about to be taken over, I wouldn't need to own a single share

Oh and good luck BillBursio in getting in below 320p any time soon.

BillBursio - your post sounds either highly ill-informed or deliberately mischievous to me. HAT does NOT have poor quality of earnings. Take a look at its financials over the past 5 years, then explain to us all what exactly's poor quality about them. Net debt has indeed gone up, partly due to a recent acquisition which will be earnings enhancing from year 1. The dividend is already increasing and is likely to continue doing so, this financial year & next. At around 3%, I wouldn't call it unexciting. Sure there are racier yields around, but with a higher yield comes the greater risk of a divi cut. HAT has also delivered significant capital growth this past year, which higher yielding shares rarely do (often quite the opposite in fact). Apart from all that, I totally agree with you.

I'm a TEK investor, but think Microsalt really needs to find its way into food manufacturers before possibly taking off. Also, anyone else noticed the shaker's American spelling "full flavor" & the disclaimer printed prominently on the front of the packs stating "This salt does not supply iodide, a necessary nutrient." I guess this may be an FDA/Food Standards requirement. But it's not great when you have to feature a product's weaknesses on the front of each pack.

djm1 - the issue’s no longer with the FDA. It’s whether Avion still want to proceed, given whatever significant guidance the FDA has given.

The price trend with PBX is certainly encouraging. But unfortunately, also irrelevant for Opti holders right now due to the lock in until 31 December 2022.